These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25091475)

  • 1. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
    Kim KI; Jang SJ; Park JH; Lee YJ; Lee TS; Woo KS; Park H; Choe JG; An GI; Kang JH
    J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
    Cai H; Wu JS; Muzik O; Hsieh JT; Lee RJ; Peng F
    J Nucl Med; 2014 Apr; 55(4):622-8. PubMed ID: 24639459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
    Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W
    J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
    Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
    J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
    Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
    Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.
    Liu S; Li D; Park R; Liu R; Xia Z; Guo J; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
    J Nucl Med; 2013 Jul; 54(7):1094-100. PubMed ID: 23667241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
    Holzer AK; Katano K; Klomp LW; Howell SB
    Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
    Jørgensen JT; Persson M; Madsen J; Kjær A
    Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.
    Peng F; Lu X; Janisse J; Muzik O; Shields AF
    J Nucl Med; 2006 Oct; 47(10):1649-52. PubMed ID: 17015901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma.
    Sadri K; Ren Q; Zhang K; Paudyal B; Devadhas D; Rodeck U; Thakur M
    Nucl Med Commun; 2011 Jul; 32(7):563-9. PubMed ID: 21572364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics of malignant melanoma with 64CuCl2.
    Qin C; Liu H; Chen K; Hu X; Ma X; Lan X; Zhang Y; Cheng Z
    J Nucl Med; 2014 May; 55(5):812-7. PubMed ID: 24627435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of
    Jiang L; Tu Y; Hu X; Bao A; Chen H; Ma X; Doyle T; Shi H; Cheng Z
    Sci Rep; 2017 May; 7(1):2574. PubMed ID: 28566692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical PET imaging study of lung cancer with
    Wang Q; Song D; Ma X; Wu X; Jiang L
    Ann Nucl Med; 2020 Sep; 34(9):653-662. PubMed ID: 32567008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNA.
    Espinoza A; Le Blanc S; Olivares M; Pizarro F; Ruz M; Arredondo M
    Biol Trace Elem Res; 2012 May; 146(2):281-6. PubMed ID: 22068728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
    Du X; Wang X; Li H; Sun H
    Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
    Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
    J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable plasma membrane levels of hCTR1 mediate cellular copper uptake.
    Eisses JF; Chi Y; Kaplan JH
    J Biol Chem; 2005 Mar; 280(10):9635-9. PubMed ID: 15634665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
    Liang ZD; Stockton D; Savaraj N; Tien Kuo M
    Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.